Invo Bioscience Stock Price To Earnings To Growth
INVODelisted Stock | USD 0.84 0.03 3.45% |
INVO Bioscience fundamentals help investors to digest information that contributes to INVO Bioscience's financial success or failures. It also enables traders to predict the movement of INVO Stock. The fundamental analysis module provides a way to measure INVO Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INVO Bioscience stock.
INVO |
INVO Bioscience Company Price To Earnings To Growth Analysis
INVO Bioscience's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, INVO Bioscience has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
INVO Fundamentals
Return On Equity | -143.59 | |||
Return On Asset | -0.27 | |||
Profit Margin | (1.23) % | |||
Operating Margin | (1.04) % | |||
Current Valuation | 15.19 M | |||
Shares Outstanding | 3.91 M | |||
Shares Owned By Insiders | 0.60 % | |||
Shares Owned By Institutions | 3.00 % | |||
Number Of Shares Shorted | 1.95 K | |||
Price To Book | 5.97 X | |||
Price To Sales | 0.56 X | |||
Revenue | 3.02 M | |||
Gross Profit | 535.27 K | |||
EBITDA | (6.63 M) | |||
Net Income | (8.03 M) | |||
Cash And Equivalents | 1.96 M | |||
Cash Per Share | 0.16 X | |||
Total Debt | 8.68 M | |||
Debt To Equity | 0.60 % | |||
Current Ratio | 1.99 X | |||
Book Value Per Share | (1.59) X | |||
Cash Flow From Operations | (4.76 M) | |||
Short Ratio | 0.04 X | |||
Earnings Per Share | 0.69 X | |||
Target Price | 20.0 | |||
Number Of Employees | 25 | |||
Beta | 1.44 | |||
Market Capitalization | 3.25 M | |||
Total Asset | 20.89 M | |||
Retained Earnings | (57.82 M) | |||
Working Capital | (6.96 M) | |||
Net Asset | 20.89 M |
About INVO Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INVO Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INVO Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INVO Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with INVO Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INVO Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving against INVO Stock
0.78 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
0.53 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.45 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.38 | HYMTF | Hyundai Motor | PairCorr |
0.34 | TLK | Telkom Indonesia Tbk | PairCorr |
The ability to find closely correlated positions to INVO Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INVO Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INVO Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INVO Bioscience to buy it.
The correlation of INVO Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INVO Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INVO Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INVO Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |